Biotech Values

[mcbio]

Another case where the FDA overruled its advisory panel, which voted that a CV trial can be done post rather than pre-approval.
Quote:
--------------------------------------------------------------------------------
...a randomized, double-blind, placebo-controlled trial of sufficient size and duration
--------------------------------------------------------------------------------

Sounds like a big and long one.

If it's deemed feasible, is it expected that Takeda would fund such a trial entirely or will OREX be responsible to some degree?